CDH1 and breast carcinoma: An unexpected high expression of E-cadherin in tumor progression was observed in aggressive brain tumor [2] and in inflammatory breast carcinoma; E-cadherin was identified as being involved in the pathogenesis of advanced breast carcinoma [3, 4].